65 related articles for article (PubMed ID: 21466125)
1. Cytosine-arabinoside stimulates the capability of human marrow stromal cells to support normal hematopoiesis.
Li H; Koh KR; Toramoto T; Nakamae H; Yamane T; Ohta K; Hino M
Osaka City Med J; 2010 Dec; 56(2):11-20. PubMed ID: 21466125
[TBL] [Abstract][Full Text] [Related]
2. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
3. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
[TBL] [Abstract][Full Text] [Related]
5. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
[TBL] [Abstract][Full Text] [Related]
6. Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cells.
Van Der Lely N; De Witte T; Muus P; Raymakers R; Preijers F; Haanen C
Exp Hematol; 1991 May; 19(4):267-72. PubMed ID: 2055291
[TBL] [Abstract][Full Text] [Related]
7. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
[TBL] [Abstract][Full Text] [Related]
8. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment].
Gotoh A; Kawanishi Y; Kurosawa K; Miyazawa K; Ohtaka M; Aizawa S; Kimura Y; Yoshikawa O; Toyama K
Rinsho Ketsueki; 1993 Jul; 34(7):821-8. PubMed ID: 7689660
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells.
Bornhäuser M; Illmer T; Le Coutre P; Pursche J; von Bonin M; Freiberg-Richter J; Schaich M; Platzbecker U; Thiede C; Ottmann OG; Köhne Ch; Braess J; Ehninger G; Schleyer E
Ann Hematol; 2004; 83 Suppl 1():S61-4. PubMed ID: 15124675
[TBL] [Abstract][Full Text] [Related]
11. Post-chemotherapy and cytokine pretreated marrow stromal cell layers suppress hematopoiesis from normal donor CD34+ cells.
Schwartz GN; Warren MK; Rothwell SW; Zujewski J; Halverson DC; Cowan KH; Tolcher A; O'Shaughnessy J; Gress RE
Bone Marrow Transplant; 1998 Sep; 22(5):457-68. PubMed ID: 9733269
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow stromal dysfunction in mice administered cytosine arabinoside.
Ben-Ishay Z; Barak V
Eur J Haematol; 2001 Apr; 66(4):230-7. PubMed ID: 11380602
[TBL] [Abstract][Full Text] [Related]
14. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone-induced stimulation of multilineage human hematopoiesis.
Hanley MB; Napolitano LA; McCune JM
Stem Cells; 2005 Sep; 23(8):1170-9. PubMed ID: 15955828
[TBL] [Abstract][Full Text] [Related]
16. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long-term stromal cultures.
Dooley DC; Oppenlander BK; Spurgin P; Mead JH; Novak FP; Plunkett M; Beckstead J; Heinrich MC
J Cell Physiol; 1995 Nov; 165(2):386-97. PubMed ID: 7593217
[TBL] [Abstract][Full Text] [Related]
19. Effect of arabinosyl cytosine on granulopoietic colony formation by marrow cells from leukemic and non-leukemic patients.
Niho Y; Till JE; McCulloch EA
Exp Hematol; 1976 Mar; 4(2):63-9. PubMed ID: 1063075
[TBL] [Abstract][Full Text] [Related]
20. [The effects of histamine H2 receptor agonist, antagonist and antineoplastic agent on the in vitro growth of PB CFU-GM from normal individuals and HL-60 leukemia cells].
He Q; Xu YH
Yao Xue Xue Bao; 1996; 31(5):340-5. PubMed ID: 9275711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
